Report cover image

Global Male Infertility Treatment Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 207 Pages
SKU # APRC20560516

Description

Summary

According to APO Research, The global Male Infertility Treatment market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Male Infertility Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Male Infertility Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Male Infertility Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Male Infertility Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Male Infertility Treatment include Zhejiang Xianju Pharmaceutical Co.,Ltd., Church & Dwight, Livzon Pharmaceutical Group Inc., Eli Lilly and Company, GeneScience Pharmaceuticals Co., Ltd., Bayer, Bristol Myers Squibb, SCSA diagnostics and Merck Serono, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Male Infertility Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Male Infertility Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Male Infertility Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Male Infertility Treatment revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Male Infertility Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Male Infertility Treatment revenue, projected growth trends, production technology, application and end-user industry.

Male Infertility Treatment Segment by Company

Zhejiang Xianju Pharmaceutical Co.,Ltd.
Church & Dwight
Livzon Pharmaceutical Group Inc.
Eli Lilly and Company
GeneScience Pharmaceuticals Co., Ltd.
Bayer
Bristol Myers Squibb
SCSA diagnostics
Merck Serono
Intas Pharma
Intas Biopharmaceuticals
Halotech DNA
Cadila
Aytu BioScience
ASKA Pharmaceutical Co., Ltd.
Andrology Solutions
Abeona Therapeutics Inc.
Male Infertility Treatment Segment by Type

Oxidative Stress Analysis
Microscopic Examination
Sperm Agglutination
Sperm Penetration Assay
DNA Fragmentation Technique
Computer Assisted Semen Analysis
Male Infertility Treatment Segment by Application

Hospitals
Clinics
Others
Male Infertility Treatment Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Male Infertility Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Male Infertility Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Male Infertility Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Male Infertility Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Male Infertility Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Male Infertility Treatment revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

207 Pages
1 Market Overview
1.1 Product Definition
1.2 Male Infertility Treatment Market by Type
1.2.1 Global Male Infertility Treatment Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Oxidative Stress Analysis
1.2.3 Microscopic Examination
1.2.4 Sperm Agglutination
1.2.5 Sperm Penetration Assay
1.2.6 DNA Fragmentation Technique
1.2.7 Computer Assisted Semen Analysis
1.3 Male Infertility Treatment Market by Application
1.3.1 Global Male Infertility Treatment Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Male Infertility Treatment Market Dynamics
2.1 Male Infertility Treatment Industry Trends
2.2 Male Infertility Treatment Industry Drivers
2.3 Male Infertility Treatment Industry Opportunities and Challenges
2.4 Male Infertility Treatment Industry Restraints
3 Global Growth Perspective
3.1 Global Male Infertility Treatment Market Perspective (2020-2031)
3.2 Global Male Infertility Treatment Growth Trends by Region
3.2.1 Global Male Infertility Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Male Infertility Treatment Market Size by Region (2020-2025)
3.2.3 Global Male Infertility Treatment Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Male Infertility Treatment Revenue by Players
4.1.1 Global Male Infertility Treatment Revenue by Players (2020-2025)
4.1.2 Global Male Infertility Treatment Revenue Market Share by Players (2020-2025)
4.1.3 Global Male Infertility Treatment Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Male Infertility Treatment Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Male Infertility Treatment Key Players Headquarters & Area Served
4.4 Global Male Infertility Treatment Players, Product Type & Application
4.5 Global Male Infertility Treatment Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Male Infertility Treatment Market CR5 and HHI
4.6.3 2024 Male Infertility Treatment Tier 1, Tier 2, and Tier 3
5 Male Infertility Treatment Market Size by Type
5.1 Global Male Infertility Treatment Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Male Infertility Treatment Revenue by Type (2020-2031)
5.3 Global Male Infertility Treatment Revenue Market Share by Type (2020-2031)
6 Male Infertility Treatment Market Size by Application
6.1 Global Male Infertility Treatment Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Male Infertility Treatment Revenue by Application (2020-2031)
6.3 Global Male Infertility Treatment Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Zhejiang Xianju Pharmaceutical Co.,Ltd.
7.1.1 Zhejiang Xianju Pharmaceutical Co.,Ltd. Comapny Information
7.1.2 Zhejiang Xianju Pharmaceutical Co.,Ltd. Business Overview
7.1.3 Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.1.4 Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Product Portfolio
7.1.5 Zhejiang Xianju Pharmaceutical Co.,Ltd. Recent Developments
7.2 Church & Dwight
7.2.1 Church & Dwight Comapny Information
7.2.2 Church & Dwight Business Overview
7.2.3 Church & Dwight Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.2.4 Church & Dwight Male Infertility Treatment Product Portfolio
7.2.5 Church & Dwight Recent Developments
7.3 Livzon Pharmaceutical Group Inc.
7.3.1 Livzon Pharmaceutical Group Inc. Comapny Information
7.3.2 Livzon Pharmaceutical Group Inc. Business Overview
7.3.3 Livzon Pharmaceutical Group Inc. Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.3.4 Livzon Pharmaceutical Group Inc. Male Infertility Treatment Product Portfolio
7.3.5 Livzon Pharmaceutical Group Inc. Recent Developments
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Comapny Information
7.4.2 Eli Lilly and Company Business Overview
7.4.3 Eli Lilly and Company Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.4.4 Eli Lilly and Company Male Infertility Treatment Product Portfolio
7.4.5 Eli Lilly and Company Recent Developments
7.5 GeneScience Pharmaceuticals Co., Ltd.
7.5.1 GeneScience Pharmaceuticals Co., Ltd. Comapny Information
7.5.2 GeneScience Pharmaceuticals Co., Ltd. Business Overview
7.5.3 GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.5.4 GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Product Portfolio
7.5.5 GeneScience Pharmaceuticals Co., Ltd. Recent Developments
7.6 Bayer
7.6.1 Bayer Comapny Information
7.6.2 Bayer Business Overview
7.6.3 Bayer Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.6.4 Bayer Male Infertility Treatment Product Portfolio
7.6.5 Bayer Recent Developments
7.7 Bristol Myers Squibb
7.7.1 Bristol Myers Squibb Comapny Information
7.7.2 Bristol Myers Squibb Business Overview
7.7.3 Bristol Myers Squibb Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.7.4 Bristol Myers Squibb Male Infertility Treatment Product Portfolio
7.7.5 Bristol Myers Squibb Recent Developments
7.8 SCSA diagnostics
7.8.1 SCSA diagnostics Comapny Information
7.8.2 SCSA diagnostics Business Overview
7.8.3 SCSA diagnostics Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.8.4 SCSA diagnostics Male Infertility Treatment Product Portfolio
7.8.5 SCSA diagnostics Recent Developments
7.9 Merck Serono
7.9.1 Merck Serono Comapny Information
7.9.2 Merck Serono Business Overview
7.9.3 Merck Serono Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.9.4 Merck Serono Male Infertility Treatment Product Portfolio
7.9.5 Merck Serono Recent Developments
7.10 Intas Pharma
7.10.1 Intas Pharma Comapny Information
7.10.2 Intas Pharma Business Overview
7.10.3 Intas Pharma Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.10.4 Intas Pharma Male Infertility Treatment Product Portfolio
7.10.5 Intas Pharma Recent Developments
7.11 Intas Biopharmaceuticals
7.11.1 Intas Biopharmaceuticals Comapny Information
7.11.2 Intas Biopharmaceuticals Business Overview
7.11.3 Intas Biopharmaceuticals Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.11.4 Intas Biopharmaceuticals Male Infertility Treatment Product Portfolio
7.11.5 Intas Biopharmaceuticals Recent Developments
7.12 Halotech DNA
7.12.1 Halotech DNA Comapny Information
7.12.2 Halotech DNA Business Overview
7.12.3 Halotech DNA Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.12.4 Halotech DNA Male Infertility Treatment Product Portfolio
7.12.5 Halotech DNA Recent Developments
7.13 Cadila
7.13.1 Cadila Comapny Information
7.13.2 Cadila Business Overview
7.13.3 Cadila Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.13.4 Cadila Male Infertility Treatment Product Portfolio
7.13.5 Cadila Recent Developments
7.14 Aytu BioScience
7.14.1 Aytu BioScience Comapny Information
7.14.2 Aytu BioScience Business Overview
7.14.3 Aytu BioScience Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.14.4 Aytu BioScience Male Infertility Treatment Product Portfolio
7.14.5 Aytu BioScience Recent Developments
7.15 ASKA Pharmaceutical Co., Ltd.
7.15.1 ASKA Pharmaceutical Co., Ltd. Comapny Information
7.15.2 ASKA Pharmaceutical Co., Ltd. Business Overview
7.15.3 ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.15.4 ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Product Portfolio
7.15.5 ASKA Pharmaceutical Co., Ltd. Recent Developments
7.16 Andrology Solutions
7.16.1 Andrology Solutions Comapny Information
7.16.2 Andrology Solutions Business Overview
7.16.3 Andrology Solutions Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.16.4 Andrology Solutions Male Infertility Treatment Product Portfolio
7.16.5 Andrology Solutions Recent Developments
7.17 Abeona Therapeutics Inc.
7.17.1 Abeona Therapeutics Inc. Comapny Information
7.17.2 Abeona Therapeutics Inc. Business Overview
7.17.3 Abeona Therapeutics Inc. Male Infertility Treatment Revenue and Gross Margin (2020-2025)
7.17.4 Abeona Therapeutics Inc. Male Infertility Treatment Product Portfolio
7.17.5 Abeona Therapeutics Inc. Recent Developments
8 North America
8.1 North America Male Infertility Treatment Revenue (2020-2031)
8.2 North America Male Infertility Treatment Revenue by Type (2020-2031)
8.2.1 North America Male Infertility Treatment Revenue by Type (2020-2025)
8.2.2 North America Male Infertility Treatment Revenue by Type (2026-2031)
8.3 North America Male Infertility Treatment Revenue Share by Type (2020-2031)
8.4 North America Male Infertility Treatment Revenue by Application (2020-2031)
8.4.1 North America Male Infertility Treatment Revenue by Application (2020-2025)
8.4.2 North America Male Infertility Treatment Revenue by Application (2026-2031)
8.5 North America Male Infertility Treatment Revenue Share by Application (2020-2031)
8.6 North America Male Infertility Treatment Revenue by Country
8.6.1 North America Male Infertility Treatment Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Male Infertility Treatment Revenue by Country (2020-2025)
8.6.3 North America Male Infertility Treatment Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Male Infertility Treatment Revenue (2020-2031)
9.2 Europe Male Infertility Treatment Revenue by Type (2020-2031)
9.2.1 Europe Male Infertility Treatment Revenue by Type (2020-2025)
9.2.2 Europe Male Infertility Treatment Revenue by Type (2026-2031)
9.3 Europe Male Infertility Treatment Revenue Share by Type (2020-2031)
9.4 Europe Male Infertility Treatment Revenue by Application (2020-2031)
9.4.1 Europe Male Infertility Treatment Revenue by Application (2020-2025)
9.4.2 Europe Male Infertility Treatment Revenue by Application (2026-2031)
9.5 Europe Male Infertility Treatment Revenue Share by Application (2020-2031)
9.6 Europe Male Infertility Treatment Revenue by Country
9.6.1 Europe Male Infertility Treatment Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Male Infertility Treatment Revenue by Country (2020-2025)
9.6.3 Europe Male Infertility Treatment Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
9.6.9 Nordic Countries
10 China
10.1 China Male Infertility Treatment Revenue (2020-2031)
10.2 China Male Infertility Treatment Revenue by Type (2020-2031)
10.2.1 China Male Infertility Treatment Revenue by Type (2020-2025)
10.2.2 China Male Infertility Treatment Revenue by Type (2026-2031)
10.3 China Male Infertility Treatment Revenue Share by Type (2020-2031)
10.4 China Male Infertility Treatment Revenue by Application (2020-2031)
10.4.1 China Male Infertility Treatment Revenue by Application (2020-2025)
10.4.2 China Male Infertility Treatment Revenue by Application (2026-2031)
10.5 China Male Infertility Treatment Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Male Infertility Treatment Revenue (2020-2031)
11.2 Asia Male Infertility Treatment Revenue by Type (2020-2031)
11.2.1 Asia Male Infertility Treatment Revenue by Type (2020-2025)
11.2.2 Asia Male Infertility Treatment Revenue by Type (2026-2031)
11.3 Asia Male Infertility Treatment Revenue Share by Type (2020-2031)
11.4 Asia Male Infertility Treatment Revenue by Application (2020-2031)
11.4.1 Asia Male Infertility Treatment Revenue by Application (2020-2025)
11.4.2 Asia Male Infertility Treatment Revenue by Application (2026-2031)
11.5 Asia Male Infertility Treatment Revenue Share by Application (2020-2031)
11.6 Asia Male Infertility Treatment Revenue by Country
11.6.1 Asia Male Infertility Treatment Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Male Infertility Treatment Revenue by Country (2020-2025)
11.6.3 Asia Male Infertility Treatment Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Male Infertility Treatment Revenue (2020-2031)
12.2 SAMEA Male Infertility Treatment Revenue by Type (2020-2031)
12.2.1 SAMEA Male Infertility Treatment Revenue by Type (2020-2025)
12.2.2 SAMEA Male Infertility Treatment Revenue by Type (2026-2031)
12.3 SAMEA Male Infertility Treatment Revenue Share by Type (2020-2031)
12.4 SAMEA Male Infertility Treatment Revenue by Application (2020-2031)
12.4.1 SAMEA Male Infertility Treatment Revenue by Application (2020-2025)
12.4.2 SAMEA Male Infertility Treatment Revenue by Application (2026-2031)
12.5 SAMEA Male Infertility Treatment Revenue Share by Application (2020-2031)
12.6 SAMEA Male Infertility Treatment Revenue by Country
12.6.1 SAMEA Male Infertility Treatment Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Male Infertility Treatment Revenue by Country (2020-2025)
12.6.3 SAMEA Male Infertility Treatment Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.